Giftify, Inc. Reports Surge in Pharmacy Retailer Gift Card Demand Following GLP-1 Medication Savings Initiative
Rhea-AI Summary
Giftify (NASDAQ: GIFT) reported a dramatic surge in pharmacy retailer gift card sales through its CardCash.com platform, with a 916% week-over-week increase in face value across major pharmacy retailers like CVS and Walgreens. The surge follows the company's introduction of a smart savings program for GLP-1 medications including Ozempic and Zepbound.
To meet growing demand, the company has significantly expanded its inventory levels, with CVS inventory growing 120% year-over-year and Walgreens inventory increasing by 736%. The initiative aims to provide cost-saving solutions for consumers purchasing high-cost prescription medications while also addressing seasonal health product demands.
Positive
- 916% week-over-week increase in pharmacy gift card sales
- 120% year-over-year growth in CVS inventory
- 736% increase in Walgreens inventory
- Strategic expansion into healthcare sector showing immediate results
Negative
- None.
Insights
Giftify's 916% week-over-week increase in pharmacy retailer gift card sales represents a noteworthy operational achievement that directly impacts revenue potential. This surge follows their strategic entry into healthcare cost-containment solutions for expensive GLP-1 medications like Ozempic and Zepbound.
The company's substantial inventory expansion for major pharmacy chains (CVS up 120% YoY and Walgreens up 736%) demonstrates management's confidence in sustained demand and represents a calculated financial commitment to support continued growth. This inventory investment is a double-edged sword - enabling capture of accelerating sales but temporarily impacting cash flow.
This initiative intelligently positions Giftify at the intersection of two high-growth markets: discount gift cards and healthcare cost management for specialty medications. The GLP-1 medication market represents a significant opportunity, with these drugs often costing patients hundreds to thousands monthly without insurance coverage.
From a financial perspective, while percentage increases are impressive, investors should consider absolute dollar impact to assess materiality. Gift card exchange platforms typically operate on thin margins, so volume scaling is essential for meaningful profit contribution. The strategy creates potential for recurring customer relationships through prescription refills, enhancing customer lifetime value and revenue predictability.
This development demonstrates Giftify's ability to identify and rapidly capitalize on emerging consumer needs while leveraging their existing platform infrastructure, suggesting improved operational efficiency and market responsiveness.
Giftify's pharmacy gift card program addresses a critical pain point in the modern healthcare landscape - affordability of breakthrough GLP-1 medications. Drugs like Ozempic and Zepbound represent a revolutionary approach to diabetes management and weight loss, but their high retail prices (often
The 916% sales surge indicates substantial unmet consumer demand for cost-reduction solutions in this medication category. What's particularly strategic about this initiative is its timing - coinciding with both GLP-1 prescription growth and seasonal health product purchasing, creating a powerful dual sales driver.
The company's significant inventory expansion suggests they've secured reliable supply chains with major pharmacy retailers, establishing an important competitive advantage in the gift card secondary market. Their ability to maintain adequate inventory levels while experiencing exponential demand growth demonstrates operational sophistication.
Beyond immediate financial impact, this positions Giftify as a participant in the healthcare affordability ecosystem. The GLP-1 medication category continues expanding as these drugs receive additional FDA approvals for new indications and growing off-label usage. As healthcare consumers become increasingly price-sensitive and digitally-savvy in seeking cost-saving solutions, Giftify's platform is now established as a resource.
This initiative cleverly leverages their existing technology platform to address healthcare affordability without requiring regulatory approvals or healthcare partnerships, allowing rapid market entry and scalability.
Record Inventory Increase Meets Growing Consumer Demand for Healthcare Cost-Saving Solutions
Surge Driven by Ozempic and Zepbound Prescription Savings Opportunities Combined with Seasonal Health Product Purchases
SCHAUMBURG, IL, March 12, 2025 (GLOBE NEWSWIRE) -- Giftify, Inc. (NASDAQ: GIFT) (the "Company"), the owner and operator of CardCash.com and Restaurant.com, and a leader in the incentives and rewards industry, today announced a significant increase in gift card sales following its announcement of a smart savings program for GLP-1 diabetes and weight loss medications.
CardCash.com, Giftify's secondary gift card exchange platform, experienced an overall
"The response to our pharmacy gift card savings initiative has exceeded our expectations," said Ketan Thakker, CEO of Giftify, Inc. "This significant growth demonstrates the value proposition of our business model and validates our strategic expansion into the healthcare sector.”
To meet this growing demand, we have significantly increased our inventory levels:
- CVS inventory levels grew by
120% year-over-year; - Walgreens inventory experienced a remarkable
736% increase.
This inventory expansion ensures CardCash can continue to meet consumer needs while maintaining competitive discount rates.
"Our latest promotional efforts have resonated strongly with consumers, leading to a measurable increase in sales activity," said Carol Rosenblum, Marketing Manager at CardCash.com. "We are committed to supporting our customers by not only offering savings on essential medications like Ozempic and Zepbound, but also ensuring convenient access to gift card solutions across our retail partners during this peak season for health-related product purchasing."
The Company has placed increased emphasis on its pharmacy gift card program to address the growing critical need for improved preventive care and affordable access to newer treatment options. By providing practical tools to reduce prescription costs, CardCash.com supports broader healthcare accessibility while expanding Giftify's market reach.
About Giftify, Inc.
Giftify, Inc. is a pioneer in the incentive and rewards industry with a focus on retail, dining & entertainment experiences, as the owner and operator of leading digital platforms, CardCash.com and Restaurant.com. CardCash.com is a leading secondary gift card exchange platform, allowing consumers and retailers to realize value by buying and selling gift cards at various scales. Its Restaurant.com is the nation’s largest restaurant-focused digital deals brand. Restaurant.com and our Corporate Incentives division connect digital consumers, businesses and communities offering thousands of dining, retail and entertainment deals options nationwide at over 184,000 restaurants and retailers. Restaurant.com prides itself on offering the best deal, every meal. Our gift cards and restaurant certificates allow customers to save at thousands of restaurants across the country with just a few clicks.
For more information, visit: www.giftifyinc.com and www.cardcash.com and https://www.restaurant.com.
Forward-Looking Statements
Press Releases may include forward-looking statements. In particular, the words “believe,” “may,” “could,” “should,” “expect,” “anticipate,” “estimate,” “project," "propose," "plan," "intend," and similar conditional words and expressions are intended to identify forward-looking statements. Any statements made in this news release about an action, event or development, are forward-looking statements. Such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the company. Accordingly, you should not place undue reliance on these forward-looking statements. Although the company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that its forward-looking statements will prove to be correct. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from those projected. The forward-looking statements in this press release are made as of the date hereof. The company takes no obligation to update or correct its own forward-looking statements, except as required by law or those prepared by third parties that are not paid by the company. Statements in this press release that are not historical fact may be deemed forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Giftify, Inc. believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Giftify, Inc. is unable to give any assurance that its expectations will be attained. Factors that could cause actual results to differ materially from expectations include the company’s ability identify a suitable business model for the corporation.
Investors Contacts:
IR@giftifyinc.com
FAQ
What caused the 916% increase in Giftify's (GIFT) pharmacy gift card sales?
How much did Giftify (GIFT) increase its pharmacy gift card inventory in 2025?
What medications are included in Giftify's (GIFT) pharmacy savings program?
Which pharmacy retailers are participating in Giftify's (GIFT) gift card program?
